Preparation method and application of multifunctional antibacterial nano delivery system

By designing the nanodrug of NO prodrug and photothermal Au nanorods, the use of near-infrared light to activate MB to generate ROS and release NO, the problem of lack of NO in diabetic wounds was solved, and efficient antibacterial and diabetic wound healing was achieved for MRSA and E.coli. and has good biocompatibility.

CN119055789APending Publication Date: 2024-12-03SHANDONG FIRST MEDICAL UNIVERSITY FIRST AFFILIATED HOSPITAL (QIANFO MOUNTAIN HOSPITAL OF SHANDONG PROVINCE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411093037.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Diabetic wounds have hindered healing due to the lack of endogenous nitric oxide (NO). Existing gaseous drug delivery methods are costly and difficult to achieve targeted and controlled release.

Method used

Design a multifunctional antibacterial nanodelivery system to self-assemble MB prodrug with polyethylene glycol-polylysine to self-assemble the bacteria-targeting phenol boric acid to form vesicles, and modify the gold nanorod on its surface to form NO Nanodies delivered by the drug and photothermal Au nanorods are used to activate MB using near-infrared light to generate ROS and release NO.

Benefits of technology

It has achieved significant antibacterial effects on MRSA and E.coli, promoted cell migration, proliferation and duct formation, significantly shortened the healing cycle of diabetic wounds, reduced inflammation, and improved biocompatibility. It is suitable for diabetic infection wounds and tissue regeneration assistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055789A_ABST
    Figure CN119055789A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a multifunctional antibacterial nano delivery system, and the preparation method comprises the following steps: modifying polyethylene glycol-polylysine with an MB prodrug and phenylboronic acid of targeted bacteria to successfully construct PEL-PBA-MB; the preparation method comprises the following steps: dissolving PEL-PBA-MB in an aqueous solution of a NO prodrug PArg, and carrying out hydrophilic and hydrophobic self-assembly to form a PEL-PBA-MB / PArg vesicle; the Au / PEL-PBA-MB / Parg nano-drug which is jointly delivered by the NO prodrug Parg and the photo-thermal Au nano-rod is formed. The multifunctional nano delivery system prepared by the invention has excellent bacterium capturing ability and antibacterial property. The phenylboronic acid modified nano-vesicles have lasting antibacterial ability and minimized body damage through cooperation of an NO antibacterial strategy and a photo-thermal antibacterial strategy. An in-vitro antibacterial experiment verifies that the nano-vesicle has a remarkable antibacterial effect on MRSA and E.coli, and the nano-vesicle can effectively release NO in a controllable manner, promote cell migration, proliferation and tube formation, reduce inflammation caused by drug-resistant bacterium infection in diabetic wounds and accelerate healing of the diabetic wounds caused by drug-resistant bacterium infection by promoting wound closure, collagen deposition and angiogenesis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biomaterial preparation, and in particular to a preparation method and application of a multifunctional antibacterial nano delivery system. Background Art

[0002] As the first barrier of the human body, the skin plays an indispensable role in resisting external forces, body immunity, sensory regulation, buffering physical or chemical stimuli, and preventing nutrient and electrolyte loss. However, the skin is the most vulnerable to injuries, including burns, abrasions, lacerations, contusions, clinical surgical operations or other surface injuries. In addition, diabetic wounds have a complex microenvironment, which is manifested by hyperglycemia, affected eNOS activity, repeated bacterial infection, disordered expression of cytokines and growth factors, increased protease activity, persistent inflammation, and impaired angiogenesis and tissue regeneration. All of these factors will hinder the healing process and prolong one or more of the four overlapping stages of wound healing, which increases the difficulty of clinical diabetic wound treatment. NO can effectively inhibit inflammation, promote angiogenesis, promote macrophage polarization, and destroy bacterial membrane permeability. Therefore, it is of great clinical significance to design a multifunctional antibacterial nanodelivery system that can effectively deliver NO, promote the healing of diabetic wounds infected with drug-resistant bacteria, and has excellent biocompatibility.

[0003] NO has been shown to accelerate the healing of acute or chronic wounds by regulating inflammation and angiogenesis, however, in most cases, endogenous NO can hardly meet the needs of therapeutic applications due to the lack of NO in the wound microenvironment. The direct method of exogenous NO for diabetic wounds is gaseous administration, but this undoubtedly increases the cost of treatment and requires complex equipment. Achieving targeted and controlled release of NO remains an urgent problem to be solved. Summary of the invention

[0004] In order to solve the above technical problems, a preparation method and application of a multifunctional antibacterial nano delivery system are provided. This technical solution solves the problem mentioned in the above background technology that endogenous NO can hardly meet the needs of therapeutic applications due to the lack of NO in the wound microenvironment. The direct method of exogenous NO for diabetic wounds is gaseous administration, but this will undoubtedly increase the cost of treatment and require complex equipment.

[0005] In order to achieve the above purpose, the technical solution adopted by the present invention is:

[0006] A method for preparing a multifunctional antibacterial nano-delivery system, comprising:

[0007] S1, MB prodrug and bacteria-targeting phenylboronic acid modified polyethylene glycol-polylysine, successfully constructed PEL-PBA-MB;

[0008] S2, dissolving PEL-PBA-MB in an aqueous solution of NO prodrug PArg, and forming PEL-PBA-MB / PArg vesicles through hydrophilic and hydrophobic self-assembly;

[0009] S3. The gold nanorods are surface modified to have a negative charge on their surface. The negatively charged Au nanorods are adsorbed on the surface of the positively charged PEL-PBA-MB / PArg vesicles through electrostatic interaction to form Au / PEL-PBA-MB / PArg nanodrugs co-delivered by NO prodrug PArg and photothermal Au nanorods.

[0010] Preferably, the MB prodrug is combined with phenylboronic acid to modify polyethylene glycol-polylysine targeting bacteria to successfully construct PEL-PBA-MB, which specifically includes the following steps: preparation of photosensitizer MB-NC, preparation of hydrophilic polymer PEL and preparation of PEL-PBA-MB.

[0011] Preferably, the preparation of the photosensitizer MB-NC specifically includes the following steps:

[0012] Toluene was added to the MB solution under nitrogen atmosphere, sodium disulfide was added under stirring at 50°C, and then anhydrous sodium carbonate was added. After stirring for 15 minutes, the toluene phase was transferred to a nitrogen-exhausted flask containing anhydrous sodium sulfate and dried under nitrogen atmosphere to obtain a liquid;

[0013] The liquid was stirred with 4-nitrobenzene chloroformate toluene solution in an ice bath, and then TEA was added. The mixture was reacted at 25°C for 12 h. The organic phase was dried, evaporated under reduced pressure, and recrystallized twice in acetonitrile to obtain MB-NP solid crystals.

[0014] MB-NP solid crystals were dissolved in anhydrous THF, and ethanolamine and TEA were added. The reaction was protected from light and refluxed at 60°C for 24 h. After evaporation under reduced pressure, column chromatography was performed for separation. The eluted solution was evaporated under reduced pressure to obtain MB-EA powder.

[0015] MB-EA powder and 4-nitrobenzene chloroformate were placed in an ice bath for 30 minutes, reacted at room temperature for 8 hours, evaporated under reduced pressure, and separated by column chromatography. The eluted solution was evaporated under reduced pressure to obtain MB-NC powder.

[0016] Preferably, the preparation of the hydrophilic polymer PEL specifically comprises the following steps:

[0017] Add triphosgene to the H-Lys(Z)-OH solution and stir for 3 h under N2 atmosphere at 50°C. Pour the resulting solution into excess n-hexane to obtain Z-Lys-NCA.

[0018] The amino-terminated polyethylene glycol was dissolved in DMF and polymerized at 50°C under N2 atmosphere for three days, and the mixture was precipitated in excess ether three times to obtain PEL (Z);

[0019] PEL(Z) was dissolved in TFA in an ice bath, stirred for 15 min, HBr was added dropwise, stirred for 1 h, and then precipitated in ether. The solution was dialyzed in distilled water for 3 days and then freeze-dried to obtain PEL.

[0020] Preferably, the preparation of the PEL-PBA-MB specifically comprises the following steps:

[0021] PEL and TEA were dissolved in anhydrous DCM, MB-NC powder was added dropwise to the solution, and the mixture was stirred at room temperature for 12 h. The reaction mixture was precipitated in ether, and the precipitate was recrystallized in ethyl acetate and then dried under reduced pressure to obtain A8;

[0022] 4-Carboxyphenylboronic acid was dissolved in DMSO and reacted with EDC and NHS for 30 minutes, then A8 was added, stirred at 37°C for 12 hours, and finally dialyzed against distilled water for 48 hours to obtain PEL-PBA-MB.

[0023] Preferably, the step of dissolving PEL-PBA-MB in an aqueous solution of NO prodrug PArg and forming PEL-PBA-MB / PArg vesicles through hydrophilic and hydrophobic self-assembly specifically comprises the following steps:

[0024] PEL-PBA-MB was dissolved in acetonitrile and stirred at 25°C for 24 h. The solution was added dropwise to deionized water in which the NO prodrug PArg was dissolved. The mixture was centrifuged at 8000 rpm for 10 min to obtain PEL-PBA-MB / PArg vesicles.

[0025] Preferably, the formation of Au / PEL-PBA-MB / PArg nanomedicine co-delivered by NO prodrug PArg and photothermal Au nanorods specifically comprises the following steps:

[0026] HAuCl4 and CTAB were mixed, and AgNO3 was added. The pH was then adjusted to 1.15 with HCl, and then ascorbic acid was added. The solution was gently shaken to change from yellow to colorless, and NaBH4 ice solution was immediately injected. The reaction was continued for 6 h, and the AuNRs were washed twice with deionized water to obtain Au@CTAB.

[0027] Sodium borohydride aqueous solution was added to Au@CTAB and incubated for 1 h, and then 11-mercaptodecanoic acid solution was added in ethanol and incubated for 12 h to obtain Au@MUA;

[0028] PEL-PBA-MB / PArg vesicles were resuspended in ultrapure water, Au@MUA and PEL-PBA-MB / PArg vesicles were resuspended, oscillated at 200 rpm for 12 h, centrifuged at 9000 rpm for 15 min, and the precipitate was resuspended in PBS to obtain Au / PEL-PBA-MB / PArg vesicle solution.

[0029] Furthermore, the present application provides a camel gelatin antibacterial nano-delivery system prepared by the method described.

[0030] Furthermore, the camel gelatin antibacterial nano-delivery system is used in medical antibacterial diabetic wound healing.

[0031] Compared with the prior art, the present invention provides a preparation method and application of a multifunctional antibacterial nano-delivery system, which has the following beneficial effects:

[0032] 1. The multifunctional nano-delivery system prepared by this invention has excellent bacterial capture ability and antibacterial properties. The phenylboronic acid-modified nanovesicles synergistically demonstrate persistent antibacterial ability and minimized body damage through NO antibacterial strategy and photothermal antibacterial strategy. In vitro antibacterial experiments have verified that it has significant antibacterial effects (>99%) on MRSA and E. coli.

[0033] 2. The multifunctional nano-delivery system prepared by this invention can effectively promote cell migration, proliferation and tube formation. The results of cell migration, proliferation and tube formation experiments show that nanovesicles can effectively and controllably release NO, promoting cell migration, proliferation and tube formation.

[0034] 3. The multifunctional nano-delivery system prepared by this invention can effectively promote the healing of diabetic wounds. The wound healing period after MRSA infection was significantly shortened by vesicle treatment. The skin healing results showed that the vesicles can immunoregulate the polarization of macrophages from pro-inflammatory M1 to anti-inflammatory M2 macrophages, reduce the inflammation of drug-resistant bacteria infection in diabetic wounds, and greatly accelerate the healing of diabetic wounds infected with drug-resistant bacteria by promoting wound closure, collagen deposition and angiogenesis.

[0035] 4. The multifunctional nano-delivery system prepared by the present invention has good biocompatibility. In vitro cytotoxicity experiments and fluorescent staining have confirmed that the vesicles have good cell compatibility, are non-irritating to human skin tissue, and meet the conditions for use in the body.

[0036] 5. The multifunctional nano-delivery system prepared by the present invention is suitable for diabetic infected wounds and tissue regeneration auxiliary materials, etc. Animal experiments have confirmed that it can significantly accelerate the healing of bacterial infected wounds without drug or cytokine delivery. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] Figure 1It is a schematic diagram of the structure of Embodiment 1-3 of the present invention;

[0038] Figure 2 1HNMR spectra of MB-NC, PEL, PEL-MB and PEL-PBA-MB in the embodiment of the present invention;

[0039] Figure 3 It is the ultraviolet spectra of MB-NC, PEL, PEL-MB and PEL-PBA-MB in the embodiment of the effect of the present invention;

[0040] Figure 4 FT-IR spectra of MB-NC, PEL, PEL-MB and PEL-PBA-MB in the embodiment of the present invention;

[0041] Figure 5 TEM images of PEL-PBA-MB and Au / PEL-PBA-MB / PArg in the embodiment of the present invention;

[0042] Figure 6 This is a characterization diagram of the antibacterial performance of Au / PEL-PBA-MB / PArg nanovesicles in the embodiment of the present invention;

[0043] Figure 7 This is a picture of Au / PEL-PBA-MB / PArg nanovesicles repairing bacterially infected wounds in diabetic mice in the effect example of the present invention. DETAILED DESCRIPTION

[0044] The following description is used to disclose the present invention so that those skilled in the art can implement the present invention. The preferred embodiments described below are only examples, and those skilled in the art may think of other obvious variations.

[0045] Please refer to Figure 1-Figure 7 As shown, a method for preparing a multifunctional antibacterial nano-delivery system comprises:

[0046] S1, MB prodrug and bacteria-targeting phenylboronic acid modified polyethylene glycol-polylysine, successfully constructed PEL-PBA-MB;

[0047] S2, dissolving PEL-PBA-MB in an aqueous solution of NO prodrug PArg, and forming PEL-PBA-MB / PArg vesicles through hydrophilic and hydrophobic self-assembly;

[0048] S3. The gold nanorods are surface modified to have a negative charge on their surface. The negatively charged Au nanorods are adsorbed on the surface of the positively charged PEL-PBA-MB / PArg vesicles through electrostatic interaction to form Au / PEL-PBA-MB / PArg nanodrugs co-delivered by NO prodrug PArg and photothermal Au nanorods.

[0049] A near-infrared (NIR) responsive NO nano-delivery system was constructed to synergistically reduce the excessive inflammatory response of diabetic wounds infected with drug-resistant bacteria through mild photothermal antibacterial and immunomodulation, so as to accelerate the healing of diabetic wounds infected with drug-resistant bacteria. Under NIR (660nm) stimulation, the quenched MB bond in the hydrophobic cavity of the vesicle breaks, MB is activated and generates a large number of reactive oxygen free radicals (ROS), which further oxidize NO prodrug polyarginine (PArg) to release NO, thereby achieving NO release responsive to NIR (660nm). In addition, NIR (808nm) can stimulate the time-power dual-regulated photothermal effect of Au nanorods.

[0050] The biological function evaluation experiment showed that phenylboronic acid (PBA) mimicking glycocalyx on polyamino acid can specifically capture bacteria and achieve specific adhesion to Gram-positive and Gram-negative bacteria. The antibacterial effect and antibacterial mechanism experiments showed that NO enhanced the permeability of near-infrared light by increasing the permeability of bacterial membranes, enhanced the sensitivity of bacteria to photothermal therapy (PTT), achieved high antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA) under mild photothermal conditions (<49.7°C), and further inhibited the outbreak of excessive inflammation induced by MRSA infection in wounds in vivo. Furthermore, NO can immunoregulate the polarization of macrophages from pro-inflammatory M1 to anti-inflammatory M2 macrophages, promote the transition from the excessive inflammation phase of bacterial infection to the tissue repair phase, minimize the inflammation of drug-resistant bacterial infection in diabetic wounds, and greatly accelerate the healing of diabetic wounds infected with drug-resistant bacteria by promoting wound closure, collagen deposition and angiogenesis. In summary, this paper developed a NIR-responsive NO-releasing nanovesicle to accelerate the healing of diabetic infection wounds by inhibiting excessive inflammation induced by drug-resistant bacterial infection.

[0051] The construction of PEL-PBA-MB specifically includes the following steps: preparation of photosensitizer MB-NC, preparation of hydrophilic polymer PEL and preparation of PEL-PBA-MB, which is described in the form of an embodiment below:

[0052] Example 1: Preparation of photosensitizer MB-NC

[0053] Dissolve 1.2 g (3.2 mmol) of methylene blue monohydrate in 100 mL of deionized water. Add 150 mL of toluene to the MB solution and flush with nitrogen. After a stable nitrogen flow is established, add 1.116 g (6.4 mmol) of sodium disulfide and then 680 mg (6.4 mmol) of anhydrous sodium carbonate at 50 ° C. After vigorous stirring for 15 minutes, the reaction mixture turns yellow and the two phases become clear, indicating that the methylene blue is transferred to the toluene phase.

[0054] The toluene phase containing L-MB was transferred to a nitrogen-exhausted flask containing anhydrous sodium sulfate and slowly added dropwise under a nitrogen atmosphere for drying. The obtained anhydrous L-MB solution containing toluene was transferred to an ice bath in a solution of 1.286g (6.4mmol) 4-nitrobenzene chloroformate dissolved with 10mL toluene. After L-MB was transferred to the chloroformate solution, 1.692mL (12.8mmol) TEA was added and reacted at room temperature overnight. Then, the product was rinsed three times with saturated sodium bicarbonate, 0.01M hydrochloric acid solution and brine in a separation funnel, and the reaction mixture was collected. The obtained organic phase was dried, evaporated under reduced pressure, and recrystallized twice in acetonitrile to obtain bright orange MB-NP solid crystals.

[0055] 450 mg (1.0 mmol) of MB-NP was dissolved in anhydrous THF and dropped into 620 mg (11.11 mmol) of ethanolamine. Then 259 μL (2.0 mmol) of TEA was added to the anhydrous THF solution. The reaction mixture was protected from light during the reaction and refluxed at 60 ° C for 24 h. After the reaction was completed, the mixture was collected, evaporated under reduced pressure, dissolved in DCM, and washed three times with saturated sodium bicarbonate solution and water respectively. The obtained organic phase was dried, evaporated under reduced pressure, and separated by column chromatography using n-hexane: ethyl acetate 1:1 and 100% acetone. The eluted solution was evaporated under reduced pressure to obtain a light blue MB-EA powder.

[0056] 400 mg (2.0 mmol) of 4-nitrobenzene chloroformate was dissolved in anhydrous DCM and added dropwise to 10 mL (35 mg / mL) of MB-EA solution in an ice bath. After 30 min of reaction in an ice-water bath, the reaction was continued for another 8 h at room temperature. The reaction mixture was washed three times with saturated sodium bicarbonate and brine respectively and then collected. The obtained organic phase was dried, evaporated under reduced pressure, and separated by column chromatography using n-hexane: ethyl acetate 2:1 and 100% acetone. The eluted solution was evaporated under reduced pressure to obtain a light brown powder as the target product MB-NC.

[0057] Example 2: Preparation of hydrophilic polymer PEL

[0058] 7.6 g of H-Lys(Z)-OH was dissolved in 80 mL of distilled THF and stirred at 50 ° C under N2 atmosphere. Then 3.4 g of triphosgene was dissolved in THF (10 mL), added dropwise to the suspension and stirred for 3 h. The resulting solution was poured into an excess of n-hexane to obtain Z-Lys-NCA. The dried 1.0 g of Z-Lys-NCA was further recrystallized twice in tetrahydrofuran / n-hexane and dried under vacuum. 2.9 g of amino-terminated polyethylene glycol was dissolved in 15 mL of anhydrous N, N-dimethylformamide (DMF) and polymerized at 50 ° C under N2 atmosphere for three days. The mixture was precipitated three times in excess ether to obtain PEL(Z). Subsequently, 10 mL of TFA was added to dissolve 500 mg of PEL(Z) in an ice bath. After stirring for 15 min, HBr (5 mL of 33% acetic acid solution) was added dropwise, stirred for another 1 h, and then precipitated in ether. After being collected and dried, the solution was resuspended in 10 mL of DMF, dialyzed in distilled water for 3 days (MWCO: 3500 Da), and finally freeze-dried to obtain PEL.

[0059] Example 3: Preparation of amphiphilic polymer PEL-PBA-MB

[0060] 1.0 g (0.2 mmoL) of PEL and 325 μL (2.5 mmol) of TEA were dissolved in anhydrous DCM. 1.48 g (2.8 mmol) of MB-NC was dissolved in anhydrous DCM, stirred continuously, and then dropped into the PEL solution. The reaction was stirred overnight at room temperature, and the reaction mixture was precipitated in ether, which was then dissolved in DCM. This process was repeated three times. Finally, the precipitate was recrystallized in ethyl acetate and then dried under reduced pressure to obtain a light blue PEL-MB powder.

[0061] 33.2 mg of 4-carboxyphenylboronic acid was dissolved in 1 mL of anhydrous DMSO and reacted with 115.8 mg of EDC and 46 mg of NHS for 30 min, then 2 g of PEL-MB was added and stirred at 37 °C for 12 h. Finally, the mixture was dialyzed with distilled water for 48 h to remove the unreacted 4-carboxyphenylboronic acid and obtain PEL-PBA-MB modified with phenylboronic acid.

[0062] Example 1-3 Preparation process Figure 1 shown.

[0063] Example 4: Preparation of gold rod Au@MUA

[0064] Mix 50mL of 1mM HAuCl4 and 50mL of 0.2M CTAB in a glass bottle, add 2.5mL of 4mM AgNO3, stir gently, then adjust the pH to 1.15 with 80μL of HCl (37%), then add 700μL of 79mM ascorbic acid, shake gently to change the solution from yellow to colorless. Immediately inject 150μL of 0.01M NaBH4 ice solution and react for 6h. The obtained AuNRs were purified after centrifugation at 20000rpm for 15min and washed twice with deionized water (DI) to remove residual CTAB.

[0065] In 1 mL of the gold rod solution, 100 μL of a 50 mM sodium borohydride aqueous solution was added and incubated for 1 h, and then 100 μL of a 10 mM 11-mercaptodecanoic acid (MUA) solution in ethanol was added and incubated for 12 h to form a self-assembled MUA monolayer on the surface.

[0066] Example 5: Preparation of Au / PEL-PBA-MB / PArg vesicles

[0067] 4 mg of PEL-PBA-MB was dissolved in 0.5 mL of acetonitrile and stirred at 25 °C for 24 h. The solution was added dropwise to 3 mL of deionized water in which 1 mg of NO prodrug PArg was dissolved. The solution was centrifuged at 8000 rpm for 10 min, and the PEL-PBA-MB / PArg vesicle supernatant was collected. Au / PEL-PBA-MB / PArg vesicles were prepared by electrostatic adsorption. PEL-PBA-MB / PArg vesicles were resuspended in 2 mL of ultrapure water. 2 mL of 50 μg mL-1 Au@MUA was centrifuged at 12000 rpm for 15 min and centrifuged twice. The Au@MUA precipitate was resuspended with the PEL-PBA-MB / PArg vesicle solution, shaken at 200 rpm for 12 h, centrifuged at 9000 rpm for 15 min, and the precipitate was resuspended in PBS. The Au / PEL-PBA-MB / PArg vesicle solution was obtained.

[0068] Effect Example

[0069] 1. 1HNMR Characterization

[0070] MB-NC, PEL, PEL-MB and PEL-PBA-MB in Examples 1-3 were used to accurately determine the chemical structures using 1HNMR. The test results are as follows: Figure 2 As shown, compared with PEL, the new proton peaks of phenothiazine at 6.8 ppm and benzene at 7.2 ppm are attributed to MB and PBA in the PEL-PBA-MB copolymer, and the grafting rate of MB is calculated to be 22%, which proves that PEL-PBA-MB is successfully prepared.

[0071] 2. UV Characterization

[0072] The structures of MB-NC, PEL, PEL-MB and PEL-PBA-MB in Examples 1 to 3 were determined by UV spectroscopy. In the UV spectrum, compared with MB-NC, PEL-PBA-MB had no absorbance peak of nitrobenzene, and new peaks of phenylboronic acid and MB appeared at 262nm and 665nm, confirming the successful functionalization of MB and PBA.

[0073] 3. FT-IR Characterization

[0074] The MB-NC, PEL, PEL-MB and PEL-PBA-MB in Examples 1-3 were used to determine the structure using FT-IR spectroscopy. In the FT-IR spectrum, compared with PEL, the new peaks at 1650 and 2915 cm-1 were attributed to C=O and NH of MB, and the new peak at 1350 cm-1 was attributed to BO of PBA in PEL-PBA-MB, further proving the successful preparation of PEL-PBA-MB.

[0075] 4. TEM Characterization of PEL-PBA-MB and Au / PEL-PBA-MB / PArg

[0076] The PEL-PBA-MB and Au / PEL-PBA-MB / PArg vesicles in Example 5 were measured by transmission electron microscopy. Figure 5 As shown in the figure, TEM results show the morphology of Au / PEL-PBA-MB / PArg, and EDS elemental maps further show that C, N, and O elements are evenly distributed in Au / PEL-PBA-MB / PArg vesicles, Cl (representing PArg) is distributed in the vesicle cavity, and Au and S elements (representing gold nanorods) are distributed on the surface of Au nanorods. Both TEM and EDS elemental maps show that Au / PEL-PBA-MB / PArg vesicles were successfully synthesized as expected, the NO donor PArg was incorporated into the hydrophilic cavity, MB was encapsulated in the hydrophobic core, and Au@MUA was electrostatically adsorbed on the surface of the nanovesicles.

[0077] 5. Characterization of Antibacterial Properties of Au / PEL-PBA-MB / PArg Nanovesicles

[0078] Bacteria were incubated with Au / PEL-PBA-MB / PArg nanovesicles, illuminated with NIR, and then transferred to agar plates for colony imaging. Figure 6As shown, the control group and the Au / PEL-PBA-MB / PArg group without NIR irradiation had almost no antibacterial effect. After NIR (660nm) irradiation, a considerable number of bacteria could be observed, indicating that the NO produced by Au / PEL-PBA-MB / PArg vesicles was insufficient to produce any antibacterial effect. Under NIR (808nm) irradiation, the colony counts of MRSA and E.coli were partially reduced by Au / PEL-PBA-MB / PArg vesicles. The reason for the poor antibacterial effect was the low photothermal temperature (49.7℃), which was significantly lower than the effective high photothermal antibacterial temperature (73℃) reported in the literature. Under NIR (808, 660) irradiation, the antibacterial efficiency of Au / PEL-PBA-MB / PArg vesicles against MRSA and E.coli was 100%.

[0079] The quantitative antibacterial efficiencies of the controls Au / PEL-PBA-MB / PArg(-), Au / PEL-PBA-MB / PArg(660), Au / PEL-PBA-MB / PArg(808), and Au / PEL-PBA-MB / PArg(808,660) against MRSA were 4.66%, 5.01%, 52.66%, and 100%, respectively, and the quantitative antibacterial efficiencies against E. coli were 5.68%, 4.66%, 59.33%, and 100%, respectively.

[0080] VI. Characterization of Au / PEL-PBA-MB / PArg nanovesicles repairing bacterially infected wounds in diabetic mice

[0081] The wound healing process was recorded during the 14-day treatment period. The wound size of each group gradually decreased over time, and the wound healing rate of the Au / PEL-PBA-MB / PArg (808, 660) group was the fastest. On the 14th day, the infected wounds in the Au / PEL-PBA-MB / PArg (808, 660) group were almost completely healed, the wound areas of the Au / PEL-PBA-MB / PArg (808) group and the Au / PEL-PBA-MB / PArg (660) group were smaller, and the wounds of the Au / PEL-PBA-MB / PArg (-) group, the commercial Tegaderm group and the control group did not heal and had large scabs. After 14 days of treatment, the wound healing rate of the Au / PEL-PBA-MB / PArg (808, 660) group was close to 99.06% ( Figure 7), while the wound healing rates of Au / PEL-PBA-MB / PArg(808), Au / PEL-PBA-MB / PArg(660), Au / PEL-PBA-MB / PArg(-), commercial Tegaderm group and control group were 82.07%, 87.28%, 73.04%, 65.39% and 60.73%, respectively, indicating that Au / PEL-PBA-MB / PArg has the best effect in accelerating wound healing under NIR (808, 660) co-irradiation.

[0082] Through the above examples and characterization analysis, we can see that the antibacterial active material MB in the present invention generates ROS to promote the release of NO from PArg, which has the antibacterial effect of sensitizing NIR, and is the key to realizing the antibacterial effect of vesicles. NO increases the permeability of the bacterial wall, making bacteria more sensitive to the photothermal effect under NIR, increasing the intracellular oxidative stress level and metabolic level, and further promoting the leakage of bacterial intracellular substances, thereby exerting a mild photothermal antibacterial effect. In addition, the release of NO promotes cell crawling and proliferation, and promotes skin healing.

[0083] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions only describe the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention. These changes and improvements fall within the scope of the present invention. The scope of protection claimed by the present invention is defined by the attached claims and their equivalents.

Claims

1. A method for preparing a multifunctional antibacterial nano-delivery system, characterized in that: include: S1, MB prodrug and bacteria-targeting phenylboronic acid modified polyethylene glycol-polylysine, successfully constructed PEL-PBA-MB; S2, dissolving PEL-PBA-MB in an aqueous solution of NO prodrug PArg, and forming PEL-PBA-MB / PArg vesicles through hydrophilic and hydrophobic self-assembly; S3. The gold nanorods are surface modified to have a negative charge on their surface. The negatively charged Au nanorods are adsorbed on the surface of the positively charged PEL-PBA-MB / PArg vesicles through electrostatic interaction to form Au / PEL-PBA-MB / PArg nanodrugs co-delivered by NO prodrug PArg and photothermal Au nanorods.

2. The method for preparing a multifunctional antibacterial nano-delivery system according to claim 1, characterized in that: The method of successfully constructing PEL-PBA-MB by modifying the MB prodrug with phenylboronic acid targeting bacteria with polyethylene glycol-polylysine specifically includes the following steps: preparation of photosensitizer MB-NC, preparation of hydrophilic polymer PEL and preparation of PEL-PBA-MB.

3. The method for preparing a multifunctional antibacterial nano-delivery system according to claim 2, characterized in that: The preparation of the photosensitizer MB-NC specifically includes the following steps: Toluene was added to the MB solution under nitrogen atmosphere, sodium disulfide was added under stirring at 50°C, and then anhydrous sodium carbonate was added. After stirring for 15 minutes, the toluene phase was transferred to a nitrogen-exhausted flask containing anhydrous sodium sulfate and dried under nitrogen atmosphere to obtain a liquid; The liquid was stirred with 4-nitrobenzene chloroformate toluene solution in an ice bath, and then TEA was added. The mixture was reacted at 25°C for 12 h. The organic phase was dried, evaporated under reduced pressure, and recrystallized twice in acetonitrile to obtain MB-NP solid crystals. MB-NP solid crystals were dissolved in anhydrous THF, and ethanolamine and TEA were added. The reaction was protected from light and refluxed at 60°C for 24 h. After evaporation under reduced pressure, column chromatography was performed for separation. The eluted solution was evaporated under reduced pressure to obtain MB-EA powder. MB-EA powder and 4-nitrobenzene chloroformate were placed in an ice bath for 30 minutes, reacted at room temperature for 8 hours, evaporated under reduced pressure, and separated by column chromatography. The eluted solution was evaporated under reduced pressure to obtain MB-NC powder.

4. The method for preparing a multifunctional antibacterial nano-delivery system according to claim 3, characterized in that: The preparation of the hydrophilic polymer PEL specifically comprises the following steps: Add triphosgene to the H-Lys(Z)-OH solution and stir for 3 h under N2 atmosphere at 50°C. Pour the resulting solution into excess n-hexane to obtain Z-Lys-NCA. The amino-terminated polyethylene glycol was dissolved in DMF and polymerized at 50°C under N2 atmosphere for three days, and the mixture was precipitated in excess ether three times to obtain PEL (Z); PEL(Z) was dissolved in TFA in an ice bath, stirred for 15 min, HBr was added dropwise, stirred for 1 h, and then precipitated in ether. The solution was dialyzed in distilled water for 3 days and then freeze-dried to obtain PEL.

5. The method for preparing a multifunctional antibacterial nano-delivery system according to claim 4, characterized in that: The preparation of the PEL-PBA-MB specifically comprises the following steps: PEL and TEA were dissolved in anhydrous DCM, MB-NC powder was added dropwise to the solution, and the mixture was stirred at room temperature for 12 h. The reaction mixture was precipitated in ether, and the precipitate was recrystallized in ethyl acetate and then dried under reduced pressure to obtain A8; 4-Carboxyphenylboronic acid was dissolved in DMSO and reacted with EDC and NHS for 30 minutes, then A8 was added, stirred at 37°C for 12 hours, and finally dialyzed against distilled water for 48 hours to obtain PEL-PBA-MB.

6. The method for preparing a multifunctional antibacterial nano-delivery system according to claim 5, characterized in that: The method of dissolving PEL-PBA-MB in an aqueous solution of NO prodrug PArg and forming PEL-PBA-MB / PArg vesicles through hydrophilic and hydrophobic self-assembly specifically comprises the following steps: PEL-PBA-MB was dissolved in acetonitrile and stirred at 25°C for 24 h. The solution was added dropwise to deionized water in which NO prodrug PArg was dissolved. The solution was centrifuged at 8000 rpm for 10 min to obtain PEL-PBA-MB / PArg vesicles.

7. The method for preparing a multifunctional antibacterial nano-delivery system according to claim 6, characterized in that: The method for forming the Au / PEL-PBA-MB / PArg nanomedicine co-delivered by NO prodrug PArg and photothermal Au nanorods specifically comprises the following steps: HAuCl4 and CTAB were mixed, and AgNO3 was added. The pH was then adjusted to 1.15 with HCl, and then ascorbic acid was added. The solution was gently shaken to change from yellow to colorless, and NaBH4 ice solution was immediately injected. The reaction was continued for 6 h, and the AuNRs were washed twice with deionized water to obtain Au@CTAB. Sodium borohydride aqueous solution was added to Au@CTAB and incubated for 1 h, and then 11-mercaptodecanoic acid solution was added in ethanol and incubated for 12 h to obtain Au@MUA; PEL-PBA-MB / PArg vesicles were resuspended in ultrapure water, Au@MUA and PEL-PBA-MB / PArg vesicles were resuspended, oscillated at 200 rpm for 12 h, centrifuged at 9000 rpm for 15 min, and the precipitate was resuspended in PBS to obtain Au / PEL-PBA-MB / PArg vesicle solution.

8. The antibacterial nano delivery system prepared by the preparation method according to any one of claims 1 to 7.

9. The antimicrobial nano delivery system of claim 8 is used for medical antimicrobial diabetic wound healing.